Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ImmuCell Corp ICCC

Healthcare Biotechnology
ImmuCell Corporation is an animal health company. The Company is engaged in the development, acquisition, manufacture, and sale of products that improve the health and productivity of dairy and beef cattle. It operates in two business segments: Scours and Mastitis. The Scours segment is engaged in manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which... see more

Recent & Breaking News (NDAQ:ICCC)

ImmuCell to Announce Financial Results for Third Quarter of 2017

GlobeNewswire November 2, 2017

ImmuCell Announces Expansion of Sales and Marketing Team

GlobeNewswire September 13, 2017

18 Biggest Mid-Day Losers For Tuesday

Benzinga.com  August 15, 2017

ImmuCell Announces Financial Results for Second Quarter of 2017

GlobeNewswire August 14, 2017

Investor Network: ImmuCell Corporation to Host Earnings Call

Accesswire August 14, 2017

ImmuCell to Announce Financial Results for Second Quarter of 2017

GlobeNewswire August 7, 2017

ImmuCell Closes $1,000,000 Equity Investment

GlobeNewswire July 27, 2017

ImmuCell Unveils New Website

GlobeNewswire July 17, 2017

ImmuCell Clarifies Number of Authorized Common Shares

GlobeNewswire July 13, 2017

ImmuCell Announces Financial Results for First Quarter of 2017

Accesswire May 11, 2017

ImmuCell to Announce Financial Results for First Quarter of 2017

Accesswire May 4, 2017

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating ImmuCell Corporation for Potential Breaches Of Fiduciary Duty By Its Board of Directors

PR Newswire April 3, 2017

Bobbi Jo Brockmann is appointed to Board of Directors of ImmuCell Corporation

Marketwired March 8, 2017

ImmuCell Secures $2 Million in Debt Financing

Marketwired March 2, 2017

ImmuCell Announces Preliminary 2016 Financial Results

Marketwired February 9, 2017

ImmuCell to Announce Preliminary 2016 Financial Results

Marketwired February 6, 2017

10 Biggest Mid-Day Losers For Tuesday

Benzinga.com  October 18, 2016

Mid-Day Market Update: Netflix Jumps On Earnings Beat; Edgewater Shares Slide

Benzinga.com  October 18, 2016

Mid-Morning Market Update: Markets Open Higher; Goldman Sachs Beats Q3 Expectations

Benzinga.com  October 18, 2016

ImmuCell Announces First Quarter 2016 Financial Results

Marketwired May 11, 2016